| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.24 | 0.06 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |